NEW YORK (GenomeWeb News) – GeneGo has won a $336,000 grant from the National Institute of General Medical Sciences, which it plans to use to create new types of signatures for drug resistance, the company said today.

GeneGo will use the Phase I Small Business Innovation Research grant in a collaboration with the Van Andel Institute for Translational Medicine that will focus on using GeneGo’s database and algorithms to identify key proteins in signaling networks.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.